fbpx
February 11, 2021

ACIP Releases 2021 Child/Adolescent Vaccine Schedule ACIP Releases 2021 Child/Adolescent Vaccine Schedule

The Centers for Disease Control and Prevention (CDC) today released the 2021 Childhood and Adolescent Immunization Schedule. It includes relatively few changes from last year’s schedule […]
February 10, 2021

Cemiplimab Now Approved for Basal Cell Carcinoma Cemiplimab Now Approved for Basal Cell Carcinoma

The Food and Drug Administration has approved cemiplimab-rwlc (Libtayo) as the first immunotherapy to treat patients with locally advanced or metastatic basal cell carcinoma (BCC) previously […]
February 10, 2021

FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID FDA Grants Emergency Use to Monoclonal Antibody Combo for COVID

Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to two […]
February 8, 2021

FDA Clears Novel Daytime Device for Obstructive Sleep Apnea FDA Clears Novel Daytime Device for Obstructive Sleep Apnea

The US Food and Drug Administration (FDA) has approved the first device to help reduce snoring and mild obstructive sleep apnea (OSA) that is used during […]
February 6, 2021

FDA OKs New CAR T- Cell Tx for Large B-cell Lymphomas FDA OKs New CAR T- Cell Tx for Large B-cell Lymphomas

The US Food and Drug Administration (FDA) has approved lisocabtagene maraleucel (Breyanzi), a chimeric antigen receptor (CAR) T-cell product for the treatment of adults with certain […]
February 5, 2021

FDA Curbs Use of COVID-19 Convalescent Plasma, Citing New Data FDA Curbs Use of COVID-19 Convalescent Plasma, Citing New Data

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has revised its emergency use […]
February 5, 2021

Tofacitinib Linked to Risk for Cardiac Events, Cancer, FDA Warns Tofacitinib Linked to Risk for Cardiac Events, Cancer, FDA Warns

The Food and Drug Administration has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase inhibitor […]
February 4, 2021

FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC

The Food and Drug Administration has granted accelerated approval for tepotinib (TEPMETKO) for the treatment of adults with metastatic non–small cell lung cancer (NSCLC) harboring MET […]
February 3, 2021

RAP Device Cleared for Short-term Improvement in Cellulite RAP Device Cleared for Short-term Improvement in Cellulite

Soliton’s Rapid Acoustic Pulse (RAP) device, which was cleared for tattoo removal in 2019, has received FDA clearance for short-term improvement in the appearance of cellulite. […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0